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Abstract
Background: Dynamic visual exploration of detailed pathway information can help researchers digest and interpret
complex mechanisms and genomic datasets.
Results: ChiBE is a free, open-source software tool for visualizing, querying, and analyzing human biological
pathways in BioPAX format. The recently released version 2 can search for neighborhoods, paths between molecules,
and common regulators/targets of molecules, on large integrated cellular networks in the Pathway Commons
database as well as in local BioPAX models. Resulting networks can be automatically laid out for visualization using a
graphically rich, process-centric notation. Profiling data from the cBioPortal for Cancer Genomics and expression data
from the Gene Expression Omnibus can be overlaid on these networks.
Conclusions: ChiBE’s new capabilities are organized around a genomics-oriented workflow and offer a unique
comprehensive pathway analysis solution for genomics researchers. The software is freely available at http://code.
google.com/p/chibe.
Keywords: Pathway informatics, Genomic data analysis
Background
A key challenge in genomics is to predict the pheno-
typic effects of genomic alterations and their combina-
tions. Genomic alterations affect phenotypic changes via
a complex interplay between multiple genes and their
products [1,2]. Decades of molecular biology research
have elucidated a substantial portion of this network,
which is currently being reconstructed at a high level
of detail that captures cellular processes such as tran-
scriptional regulation, post-translational modification,
transport, and complex formation in the formal and
computable BioPAX format [3]. The corpus of publicly
available biological pathway data in the BioPAX for-
mat is continuously expanding, both in terms of cellular
processes coverage and the level of curation detail [4].
These computable models of cellular processes can sub-
stantially improve high-throughput data analysis by link-
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ing correlation to causation. The current landscape of
high-throughput profile analysis, however, is dominated
by correlation-based methods that are either ab initio
or that use gross simplifications of biological processes
[5-9], which can only capture relatively straightforward
associations. There are three equally important techni-
cal challenges in making rich pathway information more
accessible to researchers: (i) finding a subset of the aggre-
gate corpus that is relevant to the biological problem at
hand; (ii) presenting this network of interest in an intuitive
manner, properly reducing complexity, and still allowing
exploration at multiple levels of detail; and (iii) mapping
high-throughput data on top of networks of interest for
analysis.
Chisio BioPAX Editor (ChiBE) [10] visualizes BioPAX
models as detailed process diagrams, displaying
molecules, complexes, reactions, and cellular compart-
ments. We developed version 2 of ChiBE with the above
goals in mind to help scientists formulate and answer bio-
logical questions by combining rich pathway information
with genomic and expression profiles. Users can use local
models or obtain them from the Pathway Commons [11]
database using advanced graph searches (neighborhoods,
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paths between molecules, or common targets/regulators)
and overlay genomic alteration data from the cBioPortal
for Cancer Genomics [12] or expression data from the
Gene Expression Omnibus (GEO) [13] (Figure 1). These
facilities are provided within the software tool, with no
need for manual download or data handling.
In the following sections, as a general demonstration
of ChiBE, we explore two example biological questions
and generate hypotheses using ChiBE. We then summa-
rize the capabilities of ChiBE version 2 and discuss how it
compares to other pathway visualization tools. For more
detailed instructions on how to use each of the available
features, please refer to the ChiBE User’s Guide (http://
www.cs.bilkent.edu.tr/~ivis/chibe/ChiBE-2.2.UG.pdf).
Implementation
ChiBE is implemented in Java and built on top of ChiEd
2.0, a generic graph visualization tool based on the Eclipse
Graph Editing Framework 3.1.1. ChiBE uses Paxtools [14]
for handling BioPAX data, and uses PATIKAmad [15] for
handling and mapping profiling data. ChiBE was designed
to be easily extensible programmatically to create custom
toolbars, tooltips, and context menus to enable domain-
specific customization.
Results and discussion
Exploring biological pathways with ChiBE
ChiBE complements and improves existing pathway analysis
in endometrial carcinoma
A recently published The Cancer Genome Atlas (TCGA)
article [16] reports genomic, transcriptomic and pro-
teomic profiling of 240 endometrial tumors. In the
pathway analysis section, the authors present a network,
discovered by searching for mutually exclusive alteration
patterns (Figure 2A). This network of binary signal trans-
duction is a useful but simplified model of the true biol-
ogy; signaling between two proteins is generally much
more complex. To explore the details of the signaling
events in this figure, we start by searching for paths of
length 1 from ERBB2 to KRAS in Pathway Commons,
using ChiBE. This search returns one reaction that cap-
tures the transfer of GTP to the RAS family of proteins
by a complex containing ERBB2. We then overlay muta-
tion and copy number alteration data from the TCGA
endometrial cancer dataset from the cBioPortal using the
portal data import dialog (Figure 2B). Upon loading the
data, gene alteration frequencies are color coded on the
related molecules in the graph. The resulting diagram
(Figure 2C) reveals that not only ERBB2, but all mem-
bers of the complex have substantial alterations. ERBB3,
for instance, has the same frequency of alterations (10%)
as ERBB2. None of the members of this complex other
than ERBB2 is mentioned in the TCGA article; however,
at least one member of this complex is altered in 35%
of patient samples (Figure 2D). Adding KRAS to this set
increases the fraction of altered samples to 49%. This
example clearly demonstrates that we can reproduce and
improve existing literature findings with ChiBE.
ChiBE identifies an altered complex in breast cancer
In this example, we start with a list of frequently mutated
genes in breast cancer. Such a list can be obtained using
the MutSig tool [17] provided by the cBioPortal. With
ChiBE, we run a “paths-between” query on the Path-
way Commons database using the top 15 mutated genes
(PIK3CA, TP53, MAP3K1, KMT2C, GATA3, CDH1,
MAP2K4, TBX3, RUNX1, PTEN, PIK3R1, AKT1, CTCF,
NCOR1, and RPGR) as the query seed with a default path
length limit of 1. This query will find the linkage between
these entities and will return them in BioPAX format. The
result is then automatically laid out using the CoSE com-
pound spring embedder algorithm [18] and displayed as a
detailed process diagram.
Because the seed proteins of interest in the query are
central in the cell, the query returns a large network,
which is hard to understand visually. To reduce the com-
plexity, ChiBE automatically hides subcellular compart-
ments for large networks in the view. This view highlights
all the seed genes and shows the connections between
them.
Figure 1 ChiBE data flow. Diagram showing the data flow between ChiBE and related resources.
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Figure 2 Steps in sample use case 1. A) A reconstruction of the pathway published in the manuscript by the TCGA network [16]. In the original
figure, alteration frequencies are shown for three subgroups of cases, but we merge these into one in this version. B) Dialog to retrieve alteration
data from the cBioPortal. C) Paths from ERBB2 to KRAS in Pathway Commons, overlayed with alteration data of endometrial cancer from the
cBioPortal. This diagram is part of the result that was automatically generated by ChiBE using the menu item “Query | Pathway Commons (Level 3) |
Paths From To”. D) Oncoprint of the related genes, generated by the cBioPortal. Genes from C are shown above the black line, and altered genes
from A are shown under the black line.
We then overlay mutation and copy number variation
data from the cBioPortal of the study “Breast Invasive Car-
cinoma (TCGA, Nature 2012)”, and generate the graph
shown in Figure 3. We notice that some of the com-
plexes contain frequently mutated (seed) genes, as well
as other genes with some significant alteration. One of
these genes is a complex containing JAK2. To focus on this
particular complex, we run a local neighborhood query
from the pop-up menu. The resulting view shows that
the PIK3CA/PIK3R1 complex in the cytoplasm binds to
a large complex of active JAK2 on the cytoplasmic mem-
brane. We can obtain details of the alterations using the
pop-up menu for each molecule (Figure 4A). We observe
that GAB2, SHC1, and GRB2 are mostly copy number
amplified in breast cancer patients. Alterations concen-
trating around a common function suggests that altering
this function can be a driver event for the cancer.
We further investigate this hypothesis by looking for
differential expression of members of this complex in
datasets submitted to GEO. Searching GEO datasets with
the keywords “tumorigenic and normal breast” returns
a dataset by Liu et al. [19]. Within ChiBE, the user can
automatically download this dataset by providing its GEO
series ID of GSE6883. After tagging normal and disease
samples using the data management dialog, node colors
are updated to code the fold changes between average
values of normal and disease samples (Figure 4C), and
fold-change values are displayed with tooltips.We observe
that SHC1 and CSF2RB are over-expressed in tumorigenic
samples more than twofold (2.21 and 2.56, respectively),
and that GAB2 is under-expressed 1.65-fold relative to
normal samples. Thus, the expression dataset also sup-
ports the idea that this complex can have some significant
function in tumorigenic behavior of breast cancer cells.
We can continue this study by performing new queries,
for instance, to retrieve the downstream paths from this
complex or its members.
The above scenario shows the benefit of integrating rich
pathway data with profiling data for exploring the biology
of a disease. ChiBE automatically downloaded, formatted,
and parsed the data. By removing these so-called “micro
barriers”, ChiBE offers efficient access to rich pathway
information for high-throughput data analysis.
Getting and working on amodel
ChiBE was designed to work with pathways represented
in the BioPAX format [3] - a community developed stan-
dard - including the latest version, Level 3. We call the
entire set of biological information loaded from a BioPAX
file (an OWL file) or obtained through a query into the
Pathway Commons database, a pathway model, or simply
a model. Each model is potentially composed of one or
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Figure 3 Paths between frequently mutated genes. The paths-between query result, with alteration data overlaid.
more pathways and their subpathways. Pathway bound-
aries and hierarchical organization are defined in the
BioPAX model by the original curator.
ChiBE draws each pathway as a separate view (Figure 5).
Users can close existing views or open new views from
the underlying model. Views can also be manipulated
graphically and saved with layout information. A model
may also be expanded by merging with another BioPAX
model (another OWL file or a Pathway Commons query),
provided both models are at the same level of BioPAX.
This option allows users to incrementally expand their
pathway model by including other BioPAX models or
queries.
The default ChiBE view uses a notation very similar
to that of the SBGN Process Description (SBGN-PD)
language [20]. Reaction nodes map to biochemical pro-
cesses, while other nodes map to pools of molecules.
Different states of the same “entity” (e.g., different phos-
phorylated forms of the same protein) are represented
separately. Node labels and colors are used to indicate
molecule pools that belong to the same entity. When pro-
filing data is overlaid on pathways, however, node colors
represent experimental values (as described later in the
paper). ChiBE provides an array of interactive tools for the
user to explore both types of views.
Retrieving amodel from Pathway Commons
Pathway Commons [11] is a collection of publicly available
pathway data from multiple organisms that enables biol-
ogists to browse and search a comprehensive collection
of pathways from multiple sources represented in a com-
mon language. Using keywords of pathways or molecules,
ChiBE can automatically query and obtain pathways from
Pathway Commons through its web service. More impor-
tantly, ChiBE can also run “graph-queries” to find con-
nections between entities, even when these connections
span multiple pathways. Available graph-based queries
that allow users to answer questions such as “Is there a
known multi-step signaling path between Protein A and
Protein B?” and “What is the network that connects these
sets of altered genes?” are discussed in detail in the follow-
ing section. One can also perform queries with keywords
and identifiers.
After obtaining a network of interest, users also have the
option to send the selected genes to DAVID bioinformat-
ics service [21] for further gene-set related analysis.
Querying for enriched reactions
Identification of altered parts of an interaction network
based on experimental data has been previously studied
[22-24]. ChiBE adapts this approach to detailed networks
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Figure 4 Steps of sample use case 2. A) The reaction of interest in a separate view displaying compartments and detailed properties of GAB2. B)
Oncoprint of altered genes, provided by the cBioPortal. C) The same reaction but this time expression data is overlaid on involved molecules.
by detecting reactions, whose list of participants are sig-
nificantly enriched with altered genes, or other genes that
are of interest to the user. The set of altered genes can
be selected among recurrently mutated and/or copy num-
ber altered genes in a TCGA study, by providing the code
of the study and significance thresholds for recurrence.
ChiBE retrieves these genes from Broad Firehose.
Graph queries
ChiBE provides several graph queries for retrieving spe-
cific portions of the cellular process network. ChiBE can
query the Pathway Commons database using its web
service interface. Alternatively, a query can be executed
locally on the currently loaded model.
Remote graph queries to Pathway Commons include:
neighborhood, paths-between, paths-from-to, and common-
stream. These queries are based on the algorithms given
in [25], with modifications to accommodate additional
BioPAX semantics such as generic molecules. In each
case, the user provides the query seed using HGNC gene
symbols [26], a path length limit, and other query param-
eters. The result of the query is merged with the current
model, allowing users to iteratively build a model using
queries.
Figure 5 ChiBE overview. ChiBE views are organized in canvasses, each displaying one or more BioPAX pathways in a graphically rich, interactive
manner. In this example, an Interferon Gamma Signaling pathway is displayed in process description notation.
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Neighborhood: This query retrieves the pathway neigh-
borhood of the seed genes. Users can search upstream,
downstream, or in both directions. By calling this query
consecutively, users can easily explore pathways.
Paths-between:This query computes a connecting net-
work between the seed genes. The connecting paths may
include linker molecules up to a user-defined threshold.
This query is especially useful for putting the results of
high-throughput screens into the pathway context.
Paths-from-to: This query is similar to the paths-
between query; the key difference is that this one takes
two sets of seeds (source and target) and brings the
merged network of all paths from a source to a target gene.
Common-stream: This query retrieves the network
composed of all genes that are at the upstream and/or
downstream of all seed genes. This query can be used
to find master regulators (upstream) or common targets
(downstream) that are signal integrators.
The queries discussed above can also be performed on
the local model. However, instead of HGNC gene sym-
bols, entities of the local model are used as the query seeds
and the search is limited to the currently loaded model in
memory.
Loading profiling data
ChiBE can use three different resources for profiling
data: the cBioPortal cancer genomic profiles, NCBI GEO
expression profiles, or tab-delimited files. With the first
two options, ChiBE automatically downloads and maps
the data on the network. The last option allows one to use
private or preliminary datasets. In that case, ChiBE asks
for a mapping between references in the tab-delimited
file and references on the network through a wizard, and
converts the data into an internal format for later use.
Loading data from the cBioPortal
The cBioPortal for Cancer Genomics [12] is a repository
of cancer genomics datasets with about 69 cancer studies
and more than 17,000 tumor samples. ChiBE accesses the
cBioPortal through its web service interface. Users choose
a cancer study, a case list, and the available genomic pro-
files to load (Figure 2B). Case lists are subsets of cases
with some common properties (predefined in the cBio-
Portal) such as all sequenced tumors. ChiBE discretizes
this data into alterations, and color codes gene alteration
ratios on the network (see Figure 2C for an example). For
continuous valued experiments, users can set thresholds
for discretization.
Loading data from the Gene Expression Omnibus
The NCBI GEO is a large repository of gene expres-
sion and other profiling data, allowing public access to
thousands of experiments. Given a GEO series ID, ChiBE
retrieves the dataset and maps on the network, automati-
cally. ChiBE displays the comparison (fold change) of the
first two experiments in the dataset by default. Users can
set the method that generates the displayed values from
the loaded experiments. They can visualize a single exper-
iment, or the average of a set of experiments, or compare
two sets of experiments. Mapped values are color coded
on the related molecules on the network, and values are
displayed with tooltips.
Managing biological complexity
Biological pathways are inherently complex and this
reflects on the pathway models. One of our key design
goals for ChiBE was to help users manage this complexity.
ChiBE has a rich selection of tools for highlighting, view-
ing and editing (including zooming and scrolling), context
sensitive property inspection, and interactive object move
and resize.
Users can create new pathway views by selecting or
highlighting a set of molecules or processes and cropping
to that particular subnetwork in a new view to reduce
complexity. Similarly, users may select or highlight parts
of the network that they are not currently interested in
and hide them. At any time during analysis, a view can be
saved as a static image (in SVG, JPEG, BMP, or PNG file
format) or in GraphML format for importing into another
graph analysis tool.
The dynamic and interactive nature of ChiBE views
requires pathways to be automatically drawn. A critical
and unique component of ChiBE is the automatic lay-
out algorithm supporting compound structures [27] used
for visualizing molecular complexes and subcellular com-
partments. This algorithm was further customized for
biological pathways to for example recognize and de-
emphasize ubiquitously present small molecules such as
ATP, nest subcellular compartments to represent biolog-
ical containment relationships, and tile members of a
molecular complex for more compact drawings.
To further reduce the complexity of large networks
and complex pathways, it can be useful to visualize
them as a simpler network. ChiBE can reduce a rich
BioPAX pathway representation to a binary network
between entities using a carefully selected set of rules
[28] and display the network as a newly created view
(Figure 6). Supported interaction types for Level 3 models
include “controls-state-change-of”, “controls-transport-
of”, “controls-expression-of”, “controls-degradation-of”,
“catalysis-precedes”, “in-complex-with”, and “neighbor-
of”. These networks can be saved on disk in the Simple
Interaction Format (SIF) for later use. A paths-between
query can be performed on a SIF file, providing a set
of genes of interest, through which one can obtain a
connected subnetwork including these genes.
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Figure 6 SIF views with ChiBE. A process diagram view (left) and its SIF view (right), showing controls-state-change relations.
ChiBE pathway representation
ChiBE pathway representation mostly complies with
SBGN Process Description notation [20]. There are, how-
ever, a few differences, mostly due to the specific BioPAX
semantics that have not been yet addressed in SBGN-
PD or conflicts with other requirements. In several other
instances, we simply chose to optimize user experience
at the cost of relatively minor conflicts with the stan-
dard (Figure 7). We are working with the SBGN com-
munity to resolve these issues and expect to be fully
compliant in the future. The differences are itemized
below.
Control on controls: In SBGN-PD, the target of an
effector arc can only be a process node, but BioPAX
allows defining controls on other controls. To
address this difference, ChiBE uses a special node
type for showing the controlled control, and directs
the effector edge to the control node.
Input and output ports: SBGN-PD uses two ports
for collecting a process node’s input and output arcs.
This feature allows unambigious drawing of
reversible reactions, but as the graph gets more
complex and node degrees increase, ports bring
additional challenges to the already difficult problem
of layout. Another side effect of the aforementioned
mismatch in representing controls is that it is hard to
draw reversible reactions for some cases. We opt to
always draw reversible reactions as two reactions in
opposite directions. As this choice also removes the
need for ports, ChiBE does not use ports, drawing
input and output arcs directly to the process node.
Generic relations: SBGN-PD does not support
abstractions such as homology relations and generic
entities. However, these are defined in BioPAX, and
they are frequently used in Pathway Commons.
ChiBE draws a distinct arc from the generic molecule
to its members.
Small molecule shape: SBGN-PD uses a circle glyph
for small molecules. The constant aspect ratio of the
circle, however, causes problems in placing labels,
especially for long small molecule names. ChiBE uses
Figure 7 Notation. Notation for process description diagrams in ChiBE.
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a single rounded rectangle glyph for all entities and
differentiates small molecules by a white background.
Comparison of ChiBE version 2 to related tools
The first version of ChiBE [10] supports BioPAX mod-
els of Level 2, experiment data overlay of tab delimited
data, and basic querying of an older version of the Path-
way Commons database. In version 2, we added support
for BioPAX models of Level 3 and modified the graph-
ical notation for better compliance with SBGN-PD. We
also developed advanced graph-based querying for both
the new version of the Pathway Commons database and
for local models. In addition, integration to the cBio-
Portal and the GEO for easy access to genomic pro-
files have been made. Without this streamlining, finding
and retrieving pathways, downloading and re-formatting
data as well as often having to perform ID mapping
take considerable effort and time for a user. Further-
more, ChiBE provides key technologies including BioPAX
input and output, full support for visualizing compound
structures such as molecular complexes and cellular
locations in SBGN, and customized pathway layout to
present this information to the user in an intuitive man-
ner. Thus, ChiBE removes technical barriers to accessing
popular network and profiling databases, making it a
unique software tool for molecular biology and genomic
researchers.
CellDesigner [29] is an excellent visual pathway editor,
comparable to ChiBE in its capacity to display rich path-
way information. It is, however, designed primarily for
pathway curation and simulation of SBML models. It cur-
rently cannot import BioPAX models, nor can it dynam-
ically perform graph-based searches and visually present
the results. PathCase [30] has similar searching capabili-
ties to ChiBE but is focused on metabolic pathways, and
cannot overlay genomic or other types of profiling data.
OmicsAnalyzer [31], a Cytoscape plugin, supports visual-
ization of omics data in a network context but because its
developers did not assume a standard network structure
or a standard omics data structure, mapping between the
data and the associated network is left to the user, which
is prohibitively complicated in most cases. The tool is also
limited to a simple interaction view, and is not capable of
representing the rich process views that ChiBE can. Inge-
nuity Systems makes a commercial software system called
IPA, which has similar dynamic searching, data overlay,
and analysis workflow capabilities to ChiBE’s but it uses
a proprietary simple interaction network representation
as opposed to the rich public pathway information that
ChiBE is based on. IPA also does not give users as much
control over how queries are performed as ChiBE does.
We believe that using a public, standard, and feature-rich
pathway representation will be increasingly important as
the public pathway corpus [4] and our capacity to use it
to answer biological questions [32] grows. There are sev-
eral other tools and Cytoscape plugins [33-36] that have
portions of ChiBE’s functionality, but none provides a
completely integrated workflow comparable to ChiBE.
Conclusions
ChiBE allows users to tap into the detailed pathway infor-
mation corpus for genomic data analysis. This would not
be possible without its three key features: process views,
specialized graph queries, and integration with genomic
data repositories. Process views show the mechanism of
events, bringing causality and context to the gene inter-
actions. Graph queries enable users to define context
specific boundaries for pathways. Automated mapping
from genomic data repositories onto pathways stream-
lines the analysis, eliminating manual formatting steps.
As demonstrated by the use cases, ChiBE’s uniquely pow-
erful visualization and analysis workflow opens up new
opportunities for scientific discovery.
Availability and requirements
• Project name: ChiBE
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